Showing 221 - 240 results of 4,547 for search '"Journal for ImmunoTherapy of Cancer"', query time: 0.16s Refine Results
  1. 221
    1160 Phosphonate-antibody-drug conjugates: a novel immunostimulatory class of ADCs driving inside-out activation of Vγ9Vδ2 T cells leading to selective tumor cell killing

    1160 Phosphonate-antibody-drug conjugates: a novel immunostimulatory class of ADCs driving inside-out activation of Vγ9Vδ2 T cells leading to selective tumor cell killing by Lilian Driessen-Engels, Roel J Arends, Désirée Damming, Wendela A Kappers, Gijs Verheijden, Mary J van Helden, Ronald C Elgersma, Daphne WJ van Kuppeveld, Dennis Waalboer, Ellen WH Santegoeds-Lenssen, Inge Leenders, Karin de Laat-Arts, Marc CBC Paradé, Menno Winkel, Anja Scholzen, Daniëlle EJW van Wijk, Diels van den Dobbelsteen, Genny Filiciotto, Laura Assink, Myrthe Rouwette, Panagiota I Spantidea, Timo K van den Berg, Wim HA Dokter, Miranda MC van der Lee

    Published 2023-11-01
    “…Journal for ImmunoTherapy of Cancer…”
    Article
  2. 222
    1436 Targeting stromal cell sialylation to overcome tumour-induced immunosuppressive effects on NK cells in colorectal cancer

    1436 Targeting stromal cell sialylation to overcome tumour-induced immunosuppressive effects on NK cells in colorectal cancer by Oliver Treacy, Hannah Egan, Sean Hynes, Aisling Hogan, Aideen E Ryan, Aoise O’Neill

    Published 2023-11-01
    “…Journal for ImmunoTherapy of Cancer…”
    Article
  3. 223
    895 Immunosuppressive signaling is activated in enzalutamide resistant prostate cancer

    895 Immunosuppressive signaling is activated in enzalutamide resistant prostate cancer by Bo Chen, William Murphy, Pengfei Xu, Chengfei Liu, Joy C Yang, Christopher Nip, Christopher P Evans, Leyi Wang, Jonathan EVan Dyke

    Published 2023-11-01
    “…Journal for ImmunoTherapy of Cancer…”
    Article
  4. 224
    1541 Stability of the gut microbiota during anti-pd1 immunotherapy defines complete response in melanoma patients

    1541 Stability of the gut microbiota during anti-pd1 immunotherapy defines complete response in melanoma patients by Massimo Barberis, Mariaelena Capone, Gabriele Madonna, Paolo A Ascierto, Luigi Buonaguro, Pier Ferrucci, Nicola Segata, Angeli DG Macandog, Carlotta Catozzi, Amir Nabinejad, Emilia Cocorocchio, Teresa Manzo, Luigi Nezi

    Published 2023-11-01
    “…Journal for ImmunoTherapy of Cancer…”
    Article
  5. 225
    775 Phase Ib/II Study of XmAb23104 (PD1 X ICOS) and XmAb22841 (CTLA-4 X LAG3) combination in metastatic melanoma refractory to prior immune checkpoint Inhibitor therapy with and without CNS disease

    775 Phase Ib/II Study of XmAb23104 (PD1 X ICOS) and XmAb22841 (CTLA-4 X LAG3) combination in metastatic melanoma refractory to prior immune checkpoint Inhibitor therapy with and wi... by Saya Jacob, Adil Daud, Zoe Quandt, Markee Micu, Katy K Tsai, Shahriar Yaghoubi

    Published 2023-11-01
    “…Journal for ImmunoTherapy of Cancer…”
    Article
  6. 226
    1501 Evidence of immune suppression in PBMC of patients newly diagnosed with ductal carcinoma in situ (DCIS)

    1501 Evidence of immune suppression in PBMC of patients newly diagnosed with ductal carcinoma in situ (DCIS) by Olivera J Finn, Sedigheh Taghinezhadsaroukalaei, Pamela Beatty, Amirhossein Mohseni

    Published 2023-11-01
    “…Journal for ImmunoTherapy of Cancer…”
    Article
  7. 227
    FOXA1 enhances antitumor immunity via repressing interferon-induced PD-L1 expression in nasopharyngeal carcinoma

    FOXA1 enhances antitumor immunity via repressing interferon-induced PD-L1 expression in nasopharyngeal carcinoma by Ying Liu, Bo Xiang, Wei Xiong, Pan Chen, Zhaoyang Zeng, Junshang Ge, Guiyuan Li, Mei Yi

    Published 2024-11-01
    “…Journal for ImmunoTherapy of Cancer…”
    Get full text
    Article
  8. 228
    Pretreatment antigen-specific immunity and regulation - association with subsequent immune response to anti-tumor DNA vaccination

    Pretreatment antigen-specific immunity and regulation - association with subsequent immune response to anti-tumor DNA vaccination by Laura E. Johnson, Brian M. Olson, Douglas G. McNeel

    Published 2017-07-01
    “…Journal for ImmunoTherapy of Cancer…”
    Get full text
    Article
  9. 229
    Ambra1 modulates the tumor immune microenvironment and response to PD-1 blockade in melanoma

    Ambra1 modulates the tumor immune microenvironment and response to PD-1 blockade in melanoma by Caroline Robert, Marco Carretta, Daniel Hargbøl Madsen, Per Guldberg, Thomas Sauter, Alex Frias, Luca Di Leo, Asier Antoranz, Loulieta Nazerai, Valérie Bodemeyer, Chiara Pagliuca, Christina Dahl, Giuseppina Claps, Giulio Eugenio Mandelli, Madhavi Dipak Andhari, Maria Pires Pacheco, Francesco Cecconi, Francesca Maria Bosisio, Daniela De Zio

    Published 2023-03-01
    “…Journal for ImmunoTherapy of Cancer…”
    Get full text
    Article
  10. 230
    198 Development, validation and concordance of two MAGE-A4 immunohistochemistry (IHC) assays to establish prognostic value of MAGE-A4 expression in synovial sarcoma

    198 Development, validation and concordance of two MAGE-A4 immunohistochemistry (IHC) assays to establish prognostic value of MAGE-A4 expression in synovial sarcoma by Dennis Williams, Elizabeth Ross, Armelle Dufresne, Nicolas Gadot, Marian Van Kerckhoven, Robert Connacher, Konstantinos Avraam, Mary Schneck, Sofie Van Rossom, Tianjiao Wang

    Published 2023-11-01
    “…Journal for ImmunoTherapy of Cancer…”
    Article
  11. 231
    Eftilagimod alpha, a soluble lymphocyte activation gene-3 (LAG-3) protein plus pembrolizumab in patients with metastatic melanoma

    Eftilagimod alpha, a soluble lymphocyte activation gene-3 (LAG-3) protein plus pembrolizumab in patients with metastatic melanoma by Christian Mueller, Andrew Haydon, Victoria Atkinson, Prashanth Prithviraj, Frederic Triebel, Chrystelle Brignone, Adnan Khattak, Melissa Eastgate, Amitesh Roy

    Published 2020-10-01
    “…Journal for ImmunoTherapy of Cancer…”
    Get full text
    Article
  12. 232
    Immune correlates of clinical parameters in patients with HPV-associated malignancies treated with bintrafusp alfa

    Immune correlates of clinical parameters in patients with HPV-associated malignancies treated with bintrafusp alfa by Renee N Donahue, Jeffrey Schlom, James L Gulley, Caroline Jochems, Julius Strauss, Yo-Ting Tsai, Nicole J Toney, David J Venzon

    Published 2022-04-01
    “…Journal for ImmunoTherapy of Cancer…”
    Get full text
    Article
  13. 233
    M2-like macrophages dictate clinically relevant immunosuppression in metastatic ovarian cancer

    M2-like macrophages dictate clinically relevant immunosuppression in metastatic ovarian cancer by Vladimir Benes, Ladislav Pecen, Jelena Pistolic, Lorenzo Galluzzi, Iva Truxova, Radek Špíšek, Lenka Kasikova, Michal Hensler, Petr Skapa, Jan Laco, Ivan Praznovec, Tomas Brtnicky, Lukas Rob, Catherine Sautes-Fridman, Ales Ryska, Jitka Fucikova, Wolf Herve Fridman, Vít Drochýtek, Sarka Vosahlikova, Karel Fiser, Jana Rakova, Tereza Lanickova, Irena Moserova, Martina Rehackova, Ludek Sojka

    Published 2020-10-01
    “…Journal for ImmunoTherapy of Cancer…”
    Get full text
    Article
  14. 234
    SPI1+CD68+ macrophages as a biomarker for gastric cancer metastasis: a rationale for combined antiangiogenic and immunotherapy strategies

    SPI1+CD68+ macrophages as a biomarker for gastric cancer metastasis: a rationale for combined antiangiogenic and immunotherapy strategies by Hong Yu, Yulong He, Changhua Zhang, Zhenzhen Zhao, Guofei Deng, Pengliang Wang, Rishun Su, Xuezeng Sun, Zizhen Wu, Zhangsen Huang, Liang Gu, Mingyu Huo, Songcheng Yin

    Published 2024-10-01
    “…Journal for ImmunoTherapy of Cancer…”
    Get full text
    Article
  15. 235
    Checkpoint therapeutic target database (CKTTD): the first comprehensive database for checkpoint targets and their modulators in cancer immunotherapy

    Checkpoint therapeutic target database (CKTTD): the first comprehensive database for checkpoint targets and their modulators in cancer immunotherapy by Yu Liu, Hao Zhang, Yuhong Zhao, He Liu, Peng Chen, Yixiao Zhang, Yuan Yao, Hong Xu, Xibao Tian, Zichu Wang, Peng Chu, Dongyu Zhao, Hongxu Liu, Chenlei Zhang, Shuyuan Chen, Caigang Liu, Yongliang Yang

    Published 2020-10-01
    “…Journal for ImmunoTherapy of Cancer…”
    Get full text
    Article
  16. 236
    1 Nilogen Oncosystem’s 3D-EXpress platform allows rapid assessment of mono and combo targeted and immune therapies using a biorepository of fresh patient tumoroids with intact tumor microenvironment

    1 Nilogen Oncosystem’s 3D-EXpress platform allows rapid assessment of mono and combo targeted and immune therapies using a biorepository of fresh patient tumoroids with intact tumo... by Jared Ehrhart, Seth Currlin, Angie Rivera, Michelle Ataya, Jasmin D’Andrea, Alliyah Humphrey, Rikhia Chakraborty, Soner Altoik

    Published 2023-11-01
    “…Journal for ImmunoTherapy of Cancer…”
    Article
  17. 237
    Insights from immuno-oncology: the Society for Immunotherapy of Cancer Statement on access to IL-6-targeting therapies for COVID-19

    Insights from immuno-oncology: the Society for Immunotherapy of Cancer Statement on access to IL-6-targeting therapies for COVID-19 by James L Gulley, Julie R Brahmer, Pedro J Romero, Francesco M Marincola, Charles G Drake, Stefani Spranger, Lisa H Butterfield, Douglas G McNeel, Alessandra Cesano, Thomas F Gajewski, Howard L Kaufman, Bernard A Fox, Leisha A Emens, Mario Sznol, Tanja D de Gruijl, Daniel S Chen, Patrick Hwu, Paolo Antonio Ascierto, Walter J Urba, Jon M Wigginton, Robert O Dillman, Michael B Atkins, Kim A Margolin, Paul M Sondel, Michael T Lotze, Ana Carrizosa Anderson, Ernest C Borden, David Kaufman, Michael J Mastrangelo, Marcela V Maus, David R Parkinson, George J Weiner, Jeffrey S Weber, F Stephen Hodi Jr

    Published 2020-05-01
    “…Journal for ImmunoTherapy of Cancer…”
    Get full text
    Article
  18. 238
    1147-E UI-101, a TLR7/8 agonist encapsulated in cholesteryl pullulan nanoparticle targeting tumor-associated macrophages via binding to DC-SIGN, elicits potent anti-tumor immunity without severe side effect

    1147-E UI-101, a TLR7/8 agonist encapsulated in cholesteryl pullulan nanoparticle targeting tumor-associated macrophages via binding to DC-SIGN, elicits potent anti-tumor immunity... by Yuka Igarashi, Ayaka Matsumoto, Tadashi Inoue, Yasunari Haseda, Nami Mizoguchi, Junki Tashiro, Takatoshi Soga, Naozumi Harada

    Published 2023-11-01
    “…Journal for ImmunoTherapy of Cancer…”
    Article
  19. 239
    Spatial colocalization and combined survival benefit of natural killer and CD8 T cells despite profound MHC class I loss in non-small cell lung cancer

    Spatial colocalization and combined survival benefit of natural killer and CD8 T cells despite profound MHC class I loss in non-small cell lung cancer by Ileana S Mauldin, Craig L Slingluff, Nolan A Wages, Timothy N J Bullock, Remziye E Wessel, Nardin Ageeb, Joseph M Obeid, Kate A Goundry, Gabriel F Hanson, Mahdin Hossain, Chad Lehman, Ryan D Gentzler, Sepideh Dolatshahi, Michael G Brown

    Published 2024-09-01
    “…Journal for ImmunoTherapy of Cancer…”
    Get full text
    Article
  20. 240
    1196 GDF-15 neutralizing antibody visugromab increases intratumoral immune cell infiltration to support bispecific T-cell engagers

    1196 GDF-15 neutralizing antibody visugromab increases intratumoral immune cell infiltration to support bispecific T-cell engagers by Sabrina Genßler, Eugen Leo, Christine Schuberth-Wagner, Markus Haake, Daniel Schaetzlein

    Published 2023-11-01
    “…Journal for ImmunoTherapy of Cancer…”
    Article

Search Tools: